VBLT - TherapeuticsMD Suspends Guidance And Other News: The Good Bad And Ugly Of Biopharma

TherapeuticsMD Provides Business Updates, Suspends Guidance Due to COVID 19

TherapeuticsMD (TXMD) announced important updates about its business operations including introducing cost reduction initiatives. The company also stated that it has decided to suspend its guidance for FY 2020. Some of the most prominent cost-cutting steps involve hiring freeze and lower fees negotiations. However, TherapeuticsMD said that it does not expect any product shortages during this time period.

TherapeuticsMD reported that its contingency plan will be implemented in a staggered manner. The implementation period includes second and third quarter of the year. Robert